CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

← D3A.0

Chapter 2 - Neoplasms (C00-D49)»Benign neuroendocrine tumors (D3A)»Benign carcinoid tumors of the appendix, large intestine, and rectum (D3A.02)

D3A.02

Benign carcinoid tumors of the appendix, large intestine, and rectum

Sub-codes (8)

  • D3A.020 Benign carcinoid tumor of the appendix
  • D3A.021 Benign carcinoid tumor of the cecum
  • D3A.022 Benign carcinoid tumor of the ascending colon
  • D3A.023 Benign carcinoid tumor of the transverse colon
  • D3A.024 Benign carcinoid tumor of the descending colon
  • D3A.025 Benign carcinoid tumor of the sigmoid colon
  • D3A.026 Benign carcinoid tumor of the rectum
  • D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.